First Hip and Knee Surgeries With ARVIS Augmented Reality Navigation System Completed

Seven surgeons in the USA have completed over 30 hip and knee arthroplasty procedures with ARVIS in a range of clinical settings.

Insight Medical Systems reports they have completed the first clinical cases with its ARVIS® wearable augmented reality navigation system in conjunction with DJO’s EMPOWR™ implants. Seven surgeons across the country navigated over 30 total hip and total knee arthroplasties.

“I am so impressed with the accuracy and simplicity of ARVIS and can’t wait to see this technology grow. Having experienced the ups and downs of robotics, Augmented Reality has an endless future improving outcomes in joint arthroplasty in a cost-effective way!” – Robert Limoni, M.D.

“ARVIS was surprisingly easy to incorporate into our surgical workflow. I found it precise and accurate without the tremendous cost and inefficiencies that robotics has introduced to our specialty. Robotics and navigation, as we know it today, will quickly be replaced by this more sophisticated technology.” – Michael Nett, M.D.

This milestone not only emphasizes the value of ARVIS in clinical use, but also the adaptability of this technology to a range of clinical settings. In the last two weeks, ARVIS was used at an orthopedic specialty hospital, community hospitals, large research hospitals, and an ambulatory surgical center (ASC). This list includes sites where the use of computer-assisted surgery is standard, but also facilities that have historically not had access to navigation technology.

“We believe technology should be an integral part of orthopedic surgery, but its benefits shouldn’t be limited to a handful of hospitals that can afford million-dollar robots. It should be accessible to smaller community hospitals and ASC’s where an increasing proportion of elective surgeries are being performed.” – Nick van der Walt, CEO, Insight Medical Systems.

With its proprietary surgical augmented reality eyepiece, ARVIS was designed to be streamlined and cost-effective, making it accessible to any facility where orthopedic surgery is being conducted.

“ARVIS is exciting because it’s computerized navigation that uses the principles of minimalization, accuracy, and currently available equipment (helmets) with minimal footprint in the OR. The navigation camera moves from a large stationary apparatus to be the surgeon. This is the next step we were looking for.” – Ayal Segal, M.D.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.